AzTrials
AzTrials

Bone Defectssinus liftNCT07824037

Endoscopic-Assisted Versus Conventional Crestal Sinus Lift

A study testing Endoscopic-guided Sinus lift and non- endoscopic sinus lift in people with Bone Defects, run by Nahla Mahmoud Awad at 1 site in Egypt.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

To compare Endoscopic-Assisted Versus Conventional Crestal Sinus Lift; bone grafting will be performed, followed by implant placement. Membrane perforation rates, surgical time, and bone density changes will be evaluated. Read more about this study

Who is it for?
Ages 21 years and older
Conditions the study is for
Bone Defects
What is being tested?
Endoscopic-guided Sinus lift and non- endoscopic sinus lift
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
24 participants
Where
1 siteEgypt
Study dates
25 May 2026to 31 Jul 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Loss of one or more maxillary posterior tooth, Patients age≥21 years, Bone height was 4-7 mm, sufficient inter-arch space and mesio-distal width.

Who cannot join

  • Parafunctional habits, Drug or alcohol abuse, uncontrolled systemic diseases that contraindicate implant surgery, pregnant women, Smokers.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Cairo University

    Cairo, Cairo Governorate, 12515

Other trials in Egypt

About this study

Official title: Clinical and Radiographic Evaluation of Endoscopic-Assisted Versus Conventional Crestal Sinus Lift: A Randomized Controlled Clinical Trial

To compare Endoscopic-Assisted Versus Conventional Crestal Sinus Lift; bone grafting will be performed, followed by implant placement. Membrane perforation rates, surgical time, and bone density changes will be evaluated.

Read the detailed description

Type of study design: A Randomized Clinical Trial Objective of the research: To compare Endoscopic-Assisted Versus Conventional Crestal Sinus Lift; bone grafting will be performed, followed by implant placement. Membrane perforation rates, surgical time, and bone density changes will be evaluated.

Steps of the research in short including the following:

  • The inclusion and exclusion criteria for patient selection. Inclusion criteria: Loss of one or more maxillary posterior tooth, Patients age≥21 years, Bone height was 4-7 mm, sufficient inter-arch space and mesio-distal width.

Exclusion criteria Parafunctional habits, Drug or alcohol abuse, uncontrolled systemic diseases that contraindicate implant surgery, pregnant women, Smokers.

  • Mention the source of the patients enrolled in the research All patients will be operated on and followed up at the Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Cairo University, Egypt.
  • A written informed consent form will be signed from the patientis required.
  • Description of the methodology. Radiographic assessment involved panoramic X-rays and cone-beam computed tomography (CBCT). CBCT analysis included evaluation of residual bone height, buccopalatal bone width, sinus pathology, bony septa, and precise measurement of Schneiderian membrane thickness at the planned implant sites Group 1(non-endoscopic-guided): Endoscopic evaluation was performed after complete osteotomy preparation and sinus membrane elevation using osteotomes.

Group 2 (Endoscopic-guided): Endoscopic evaluation was conducted after each drilling step, osteotome malleting, and bone graft placement to monitor sinus membrane integrity.

Sample size calculation.

  • Randomization in case of RCT. Patients will be divided into two groups based on treatment type using block randomization of block size 4. An independent statistician will generate the random sequence using a computer-generated random number list method by (https://www.randomizer.org/).
  • Number of visits \& follow up period. ( 4 visits)

Patients in both groups will be followed up at 24-hours, one, three, six, months postoperatively to assess this parameter:

  1. Membrane integrity intraoperative.
  2. Surgical intraoperative time.
  3. Radiographically, mean bone density will be measured (immediate post-operative and post 6 months CBCT)
Conditions
Bone Defects
Being tested
Endoscopic-guided Sinus lift, non- endoscopic sinus lift
Keywords
Maxillary sinus augmentation, Posterior maxillary implants, Sinus endoscopy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Endoscopic-guided Sinus liftProcedure or surgery

    12 patients in Group 2 (Endoscopic-guided): Endoscopic evaluation was conducted after each drilling step, osteotome malleting, and bone graft placement to monitor sinus membrane integrity.

  • non- endoscopic sinus liftProcedure or surgery

    12 patients in Group 1(non-endoscopic-guided): Endoscopic evaluation was performed after complete osteotomy preparation and sinus membrane elevation using osteotomes.

Study groups in NCT07824037
Study groupRoleWhat they receive
Endoscopic-guided sinus liftExperimentalEndoscopic-guided sinus lifting
Receives: Procedure: Endoscopic-guided Sinus lift
non-endoscopic-guided sinus liftPlacebo comparatorconventional sinus lift
Receives: Procedure: non- endoscopic sinus lift

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Membrane integrity intraoperative.

    Membrane remains intact ( no perforation)

    Measured: 24 hours

Secondary outcomes (1)
  1. mean bone density

    CBCT

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Sep 2026
  2. Study start25 May 2026
  3. Primary completion31 May 2028 (estimated)
  4. Study completion31 Jul 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Single group
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07824037
Sponsor's protocol ID
25526
Acronym
sinus lift
Status last verified
May 2026
First submitted
11 Sep 2026
Last updated
17 Sep 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Endoscopic-guided Sinus lift and non- endoscopic sinus lift in people with Bone Defects, run by Nahla Mahmoud Awad at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 17 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Membrane integrity intraoperative. (time frame: 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in